FOUNDER AND CEO
Molecular neurobiologist with over 15 years of experience in protein and prion biology, specializing in the mechanisms of protein misfolding and their implications in both cancer and neurodegenerative diseases. With a strong background spanning both academia and industry, she bridges the gap between molecular biology and therapeutic development, driving innovative translational science. Dr. Ganti has extensive expertise in drug development and regulatory affairs, having led successful regulatory submissions, adaptive clinical trial designs, and business development initiatives.

ADVISOR, BUSINESS DEVELOPMENT
A seasoned biotech entrepreneur and strategic leader, Alain Van Loo brings extensive experience in venture capital, life sciences, and biotechnology innovation. He specializes in identifying and nurturing high-potential companies addressing critical unmet medical needs. With expertise in investment strategy, business development, and board leadership, Alain has a proven track record of driving growth, guiding startups, fostering collaborations, and advancing technologies to improve patient outcomes.

STRATEGIC ADVISOR
Renowned leader in strategy consulting and industry innovation, currently serving as the Chairman of Bain & Company India and a trusted advisor to global organizations across diverse sectors. With decades of experience, Ashish excels in corporate strategy, mergers and acquisitions, and performance optimization, helping businesses overcome complex challenges and achieve sustainable growth. His expertise spans industries such as healthcare, life sciences, technology, and financial services, where he has consistently driven transformative change. Ashish has played a pivotal role in enabling organizations to seize emerging opportunities, navigate market disruptions, and deliver long-term value.

DIRECTOR, ADVOCACY AND ALLIANCES
An accomplished Speech-Language Specialist with exceptional skills in communication strategy, relationship-building, and tailored interventions, with a strong focus on fostering developmental growth in young learners. Davisha brings expertise in stakeholder engagement, strategic partnerships, and advocacy initiatives to drive the company’s mission forward. Adept at forging meaningful alliances, fostering collaborative solutions, and amplifying organizational impact through innovation and a steadfast commitment to transforming lives.

Chief of Behavioral Neurology and retired Director of the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease at Northwestern University Feinberg School of Medicine, is a renowned expert in Alzheimer's disease and neurodegenerative disorders. Celebrated for his deep insights into brain anatomy, cognition, and language, he played a pivotal role in defining the mild cognitive impairment (MCI) stage, marking a critical milestone in the advancement of early diagnostic and therapeutic strategies for AD.

A recognized authority on protein homeostasis, prion biology, and protein aggregation, Dr. Garcia is renowned for advancing the understanding of chaperone mechanisms and their critical roles in disease progression. Her work has provided key insights into how molecular chaperones influence protein folding, stability, and aggregation, contributing significantly to the development of therapeutic strategies for neurodegenerative diseases where protein misfolding is a central feature.

Professor of Medicine at Emory University and Chief of Diabetes and Endocrinology at Grady Health System, is a leading expert in diabetes and metabolic disorders, with a focus on the gut-brain axis and its role in disease processes. His pioneering research examines how gut microbiota, intestinal permeability, and inflammation influence metabolic and neurological health, driving innovative therapeutic approaches across a range of conditions.

Professor of Biological Sciences at Bethel University and a leading expert in cancer biology, focusing on the role of the cytoskeleton in cancer progression and metastasis. With a strong foundation in cancer research from Stanford University, she specializes in exploring the molecular mechanisms that drive cancer development and invasion.